Key result
This review highlights the NO-mediated regulation of proximal tubular Na+ transport and its crosstalk with Angiotensin II signaling as a potential human-specific therapeutic target for hypertension.
This review highlights a newly identified human-specific pathway where Angiotensin II stimulates proximal tubular Na+ transport via NO/cGMP, presenting a potential therapeutic target for hypertension.
NO's debated renal natriuretic effects warrant no practice change; leaves open its net tubular role for targeted studies.
Nitric oxide (NO) has a wide variety of physiological functions in the kidney. Besides the regulatory effects in intrarenal haemodynamics and glomerular microcirculation, in vivo studies reported the diuretic and natriuretic effects of NO. However, opposite results showing the stimulatory effect of NO on Na + reabsorption in the proximal tubule led to an intense debate on its physiological roles. Animal studies have showed the biphasic effect of angiotensin II (Ang II) and the overall inhibitory effect of NO on the activity of proximal tubular Na + transporters, the apical Na + /H + exchanger isoform 3, basolateral Na + /K + ATPase, and the Na + /HCO3-cotransporter. However, whether these effects could be reproduced in humans remained unclear. Notably, our recent functional analysis of isolated proximal tubules demonstrated that Ang II dose-dependently stimulated human proximal tubular Na + transport through the NO/guanosine 3′,5′-cyclic monophosphate (cGMP) pathway, confirming the human-specific regulation of proximal tubular transport via NO and Ang II. Of particular importance for this newly identified pathway is its possibility of being a human-specific therapeutic target for hypertension. In this review, we focus on NO-mediated regulation of proximal tubular Na + transport, with emphasis on the interaction with individual Na + transporters and the crosstalk with Ang II signalling.
No takes yet. Share an insight, caveat, or question.
Satoh et al. (2017) conducted a review in Hypertension. Nitric oxide was evaluated. This review highlights the NO-mediated regulation of proximal tubular Na+ transport and its crosstalk with Angiotensin II signaling as a potential human-specific therapeutic target for hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: